we also feel that EXEL is the superior value option right now. 7 Best Stocks for the Next 30 Days Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys.

The sales of syringes and needles in the Gulf Cooperation Council (GCC) region are expected to witness steady growth, with a projected compound annual growth rate (CAGR) of 5.40% through 2034. Market ...

Figure 1. (A) Male and (B) female Luer connector drawings. The working principle in Luer Slip connectors is based on the fitting between the external face of the male connector and the internal face ...

The best smart locks offer keyless convenience without sacrificing security. You can use yours to automatically open up when you're carrying shopping to the door, to give access to loved ones who ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Exelixis (EXEL) reports results for ... to be $561.76 million, up 17.1% from the year-ago quarter.

Busà Photography / Getty Images Many people believe that being wealthy means having a nice house, a late-model car, and a summer cottage, but the kind of money possessed by the wealthiest 1% of ...

Adding to its momentum, EXEL recently partnered with pharmaceutical heavyweight Merck & Co., Inc. (MRK) to explore zanzalintinib’s potential combined with MRK’s blockbuster PD-1 therapy Keytruda ...

Locals near a needle exchange site in a Bronx park are cheering a councilman’s proposal to require city health workers to collect hundreds of discarded syringes littering the ground. Oswald ...

In its prior filing, the firm reported owning 15,163K shares , representing an increase of 1.28%. The firm increased its portfolio allocation in EXEL by 3.72% over the last quarter. IJH - iShares ...

On Monday, Exelixis (NASDAQ:EXEL) shares, with a market capitalization ... contributing to full-year product sales around $1.805 billion, marking an 11% year-over-year growth.